Linifanib (GMP), CAS [[796967-16-3]]

Produktübersicht

• Artikelname: Linifanib (GMP), CAS [[796967-16-3]]
• Artikelnummer: MCE-HY-50751G
• Hersteller Artikelnummer: HY-50751G
• Alternativnummer: MCE-HY-50751G-100MG,MCE-HY-50751G-50MG,MCE-HY-50751G-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-869 (GMP), AL-39324 (GMP)

Produktbeschreibung

Linifanib (ABT-869) (GMP) is Linifanib (HY-50751) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Linifanib is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRbeta, and FLT3, respectively. Linifanib (GMP) promotes the generation and reprogramming of iPSCs from somatic cells[1].

Produkteigenschaften

• Molekulargewicht: 375.40
• Reinheit: 99.9
• CAS Nummer: [796967-16-3]
• Formel: C21H18FN5O
• Target-Kategorie: PDGFR,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: GMP Small Molecules